Amarin

The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Sat, 02/4/12 - 03:30 pm
Theratechnologies
SeraCare Life Sciences
Gentium
Curis
BioDelivery Sciences
Amarin
Affymetrix
Affymax
Vertex Pharmaceuticals
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sun, 01/22/12 - 12:20 pm
Vertex Pharmaceuticals
Chelsea Therapeutics
ONYX Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Cell Therapeutics
Amarin CEO Seeks Redemption And Investors at JP Morgan Conference
TheStreet.com
Tue, 01/10/12 - 09:44 am
Amarin
JPMorgan
Pharma CEOs
Joe Zakrzewski
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Mon, 12/5/11 - 06:13 pm
ONYX Pharmaceuticals
Vertex Pharmaceuticals
Amarin
Chelsea Therapeutics
Cell Therapeutics
Every Biotech Is for Sale
Motley Fool
Wed, 11/30/11 - 10:45 am
ONYX Pharmaceuticals
Achillion
BioSante
Indenix
Inhibitex
GSK
Bristol-Myers Squibb
Amarin
Exelixis
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
7 Black Friday Biotech Bargains
Motley Fool
Sat, 11/26/11 - 10:50 am
Dendreon
Human Genome Sciences
GSK
Avanir
Exelixis
MannKind
Amarin
Vertex Pharmaceuticals
Amarin Omega-3 Medication
Investor's Business Daily
Sat, 11/26/11 - 10:46 am
Amarin
AMR101
omega-3 fatty acid
Amarin Stabilizes Ahead Of FDA Decision
Seeking Alpha
Wed, 11/16/11 - 09:49 am
Amarin
FDA
AMR101
Amarin CEO Refuses to Discuss Drug Patent Issues Killing His Stock Price
TheStreet.com
Wed, 11/9/11 - 09:13 am
Amarin
Joe Zakrzewski
patents
AMR101
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Achillion
Aeterna Zentaris
Antigenics
Ariad
Amylin
Amarin
BioDelivery Sciences
Cyclacel
Geron
Dendreon
PharmAthene
Zalicus
Human Genome Sciences
Keryx
Peregrine Pharmaceuticals
SIGA technologies
YM BioSciences
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Human Genome Sciences
Vertex Pharmaceuticals
Lexicon Pharmaceuticals
Amarin
Exelixis
Dendreon
Acorda Therapeutics
2 Healthcare Companies Expecting September Catalysts
Seeking Alpha
Thu, 09/1/11 - 08:03 am
Amarin
AMR101
Iluvien
Alimera
Amarin Gets Final Rejection on Key Drug Patent
TheStreet.com
Thu, 08/18/11 - 09:22 am
patents
Amarin
AMR101
Amarin Gets 1 Step Closer to the Big Time
Motley Fool
Fri, 08/12/11 - 08:10 am
Amarin
fish oil
AMR101
Amarin Reports Second Quarter 2011 Results
Yahoo
Wed, 08/10/11 - 10:51 am
Amarin
earnings
The Race: FDA Approval or Buyout?
Motley Fool
Tue, 08/2/11 - 04:12 pm
FDA
Amarin
AMR101
4-Star Stocks Poised to Pop: Amarin
Motley Fool
Mon, 07/25/11 - 10:51 am
Amarin

Pages